Related Experiment Video
Updated: Aug 17, 2026
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
Intra-nigral MPTP lesion in rats: behavioral and autoradiography studies
Juliana C Perry1, Débora C Hipólide, Sergio Tufik
1Universidade Federal do Paraná, Setor de Ciências Biológicas, Departamento de Farmacologia, Av. Francisco H. dos Santos s/n, CEP: 81.531-990, Caixa Postal: 19031, Curitiba-Paraná, Brazil.
Abstract:
The present study investigated the motor response and possible changes in binding to D1 and D2 receptors after intra-nigral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) infusion on rats. The results indicated that MPTP-lesioned rats exhibited a significant reduction in locomotion and rearing frequencies observed in an open field 24 h after surgery. However, at 7 and 14 days after surgery the MPTP-lesioned rats showed a significant increase in locomotion in comparison to the control groups, as well as a decrease in immobility time. In addition, 21 days after surgery the behavioral measurements were unaltered by these procedures. Moreover, latency in initiating movement and catalepsy were unchanged by this neurotoxin on the same days of observation. An autoradiography approach indicated that there was a reduction in [3H]SCH 23390 binding in substantia nigra pars compacta (SNpc), substantia nigra pars reticulata (SNpr) and ventrolateral striatum in MPTP-treated rats 21 days after the surgery. [3H]raclopride binding remained unaltered by the MPTP treatment. These results suggest that compensatory plastic changes occur in D1 dopamine receptors after partial lesion of nigral dopaminergic neurons. These alterations might be related to the occurrence and recovery of motor impairment observed in MPTP-lesioned rats.
Insights
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rats caused initial motor deficits, followed by recovery linked to D1 dopamine receptor changes. These findings suggest neural plasticity in dopamine pathways.
Area of Science:
- Neuroscience
- Pharmacology
- Neurobiology
Background:
- Parkinson's disease models often utilize 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to induce dopaminergic neurodegeneration.
- Understanding dopamine receptor alterations is crucial for developing effective Parkinson's disease therapies.
Purpose of the Study:
- To investigate motor function recovery and dopamine receptor binding changes after MPTP-induced neurotoxicity in rats.
- To explore the role of D1 and D2 dopamine receptors in the adaptive mechanisms following nigral dopaminergic neuron damage.
Main Methods:
- Intra-nigral administration of MPTP in a rat model.
- Behavioral testing in an open field to assess locomotion, rearing, and immobility.
- Autoradiography to quantify [3H]SCH 23390 (D1 receptor) and [3H]raclopride (D2 receptor) binding.
Main Results:
- MPTP-lesioned rats showed initial reductions in locomotion, followed by significant recovery at 7 and 14 days post-surgery.
- A decrease in D1 receptor binding was observed in specific brain regions (SNpc, SNpr, ventrolateral striatum) 21 days after MPTP infusion.
- D2 receptor binding remained unaffected by MPTP treatment.
Conclusions:
- Compensatory plastic changes in D1 dopamine receptors occur after partial nigral dopaminergic neuron lesions.
- These D1 receptor alterations may contribute to the observed recovery of motor impairments in MPTP-treated rats.
- The study highlights the dynamic nature of dopamine receptor systems in response to neurotoxic injury.
